Home › Companies › MEDPACE HOLDINGS INC. › 2024-2025
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and MEDPACE HOLDINGS INC.’s Form 8-K, filed May 16, 2025 (Item 5.07 on EDGAR). Page generated November 20, 2026.
Meeting of May 16, 2025: 6 items on MEDPACE HOLDINGS INC.’s Form 8-K, filed May 16, 2025: 2 elected · 4 approved.
High dissent: 1 shareholder proposal (69.4% support).
Notable dissent: 1 director (19.5% against).
Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided
Explore MEDPACE HOLDINGS INC. in the interactive database Compare manager voting policies
These tallies are MEDPACE HOLDINGS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed May 16, 2025 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: August J. Troendle | 21,156,998 | -- | -- | 5,128,383 | 1,533,208 | 80% | Elected | — |
| Elect Director: Dani S. Zander | 25,858,694 | -- | -- | 426,687 | 1,533,208 | 98% | Elected | — |
| 2. Ratification of Appointment of Independent Registered Public Accounting Firm The appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025 | 27,200,285 | 600,429 | 17,875 | -- | -- | 98% | Approved | — |
| 3. Advisory Vote on the Compensation of our Named Executive Officers The proposal to approve, on an advisory basis, the compensation of the Company's Named Executive Officers | 24,918,234 | 1,340,033 | 27,114 | -- | 1,533,208 | 95% | Approved | — |
| 4. Approval of the Company's 2016 Amended and Restated Incentive Award Plan The proposal to approve the Company's 2016 Amended and Restated Incentive Award Plan | 25,567,981 | 702,406 | 14,994 | -- | 1,533,208 | 97% | Approved | — |
| 5. Advisory Vote on Stockholder Proposal The non-binding advisory stockholder proposal regarding simple majority voting | 18,210,462 | 8,021,457 | 53,462 | -- | 1,533,208 | 69% | Approved | — |
Source: MEDPACE HOLDINGS INC., Form 8-K, filed with the SEC on May 16, 2025 — read the filing on EDGAR.
See voting trends for Health Care companies, 2024-2025: shareholder support by sector and by company size.
556 asset managers disclosed a vote on at least one MEDPACE HOLDINGS INC. item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report.
Combines 8 wordings of this item as funds reported it.
80% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: August J. Troendle
MEDPACE HOLDINGS INC.’s own tally for this item (“Elect Director: August J. Troendle”): 21,156,998 for, 5,128,383 withheld, per its Form 8-K filed May 16, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “(b) Stockholders voted on the matters set forth below: Proposal 1 — Election of Directors The following nominees were elected to the Company's Board of Directors to serve as Class III Directors until the Company's 2026 Annual Meeting of Stockholders based upon the following votes:”
Support: 80% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 128 asset managers below reported 7,538,928 for, 1,098,706 withheld, 206,083 abstained, 57 not voted.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,723,013 | 0 | 0 | 66,320 | For |
| BlackRock | 1,573,065 | 0 | 0 | 0 | For |
| Fidelity | 681,637 | 0 | 0 | 7,200 | For |
| WASATCH FUNDS TRUST | 430,392 | 0 | 0 | 0 | For |
| Invesco | 329,184 | 0 | 0 | 0 | For |
| Dimensional | 0 | 0 | 0 | 201,673 | Withhold |
| Charles Schwab | 198,966 | 0 | 0 | 0 | For |
| OLD WESTBURY FUNDS INC | 0 | 0 | 0 | 187,684 | Withhold |
| Legg Mason | 173,916 | 0 | 0 | 2,140 | For |
| State Street | 161,897 | 0 | 0 | 110 | For |
| Manager Directed Portfolios | 131,563 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 130,635 | 0 | 0 | 0 | For |
| Thrivent | 0 | 0 | 0 | 120,238 | Withhold |
| Putnam | 85,202 | 0 | 0 | 0 | For |
| CARILLON SERIES TRUST | 0 | 0 | 84,045 | 0 | Abstain |
| JPMorgan | 80,308 | 0 | 0 | 0 | For |
| Goldman Sachs | 77,395 | 0 | 0 | 0 | For |
| Capitol Series Trust | 0 | 0 | 0 | 73,213 | Withhold |
| T. Rowe Price | 70,983 | 0 | 0 | 0 | For |
| TIAA | 59,129 | 0 | 0 | 0 | For |
| BOSTON TRUST WALDEN FUNDS | 0 | 0 | 0 | 48,640 | Withhold |
| Jackson National | 0 | 0 | 48,623 | 0 | Abstain |
| Bridge Builder Trust | 27,916 | 0 | 17,593 | 0 | Mixed |
| John Hancock | 14,682 | 0 | 29,744 | 0 | Mixed |
| Advisers Investment Trust | 42,400 | 0 | 0 | 0 | For |
Showing the 25 largest of 128 asset managers. All 128 are in the interactive database (link above).
Combines 8 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Dani S. Zander
MEDPACE HOLDINGS INC.’s own tally for this item (“Elect Director: Dani S. Zander”): 25,858,694 for, 426,687 withheld, per its Form 8-K filed May 16, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “(b) Stockholders voted on the matters set forth below: Proposal 1 — Election of Directors The following nominees were elected to the Company's Board of Directors to serve as Class III Directors until the Company's 2026 Annual Meeting of Stockholders based upon the following votes:”
Support: 98% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 128 asset managers below reported 8,836,584 for, 5,844 withheld, 1,289 abstained, 57 not voted.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,789,140 | 0 | 0 | 193 | For |
| BlackRock | 1,573,065 | 0 | 0 | 0 | For |
| Fidelity | 688,837 | 0 | 0 | 0 | For |
| WASATCH FUNDS TRUST | 430,392 | 0 | 0 | 0 | For |
| Invesco | 329,184 | 0 | 0 | 0 | For |
| Dimensional | 201,673 | 0 | 0 | 0 | For |
| Charles Schwab | 198,966 | 0 | 0 | 0 | For |
| OLD WESTBURY FUNDS INC | 187,684 | 0 | 0 | 0 | For |
| Legg Mason | 176,056 | 0 | 0 | 0 | For |
| State Street | 162,007 | 0 | 0 | 0 | For |
| Manager Directed Portfolios | 131,563 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 130,635 | 0 | 0 | 0 | For |
| Thrivent | 120,238 | 0 | 0 | 0 | For |
| Putnam | 85,202 | 0 | 0 | 0 | For |
| CARILLON SERIES TRUST | 84,045 | 0 | 0 | 0 | For |
| JPMorgan | 80,308 | 0 | 0 | 0 | For |
| Goldman Sachs | 77,395 | 0 | 0 | 0 | For |
| Capitol Series Trust | 73,213 | 0 | 0 | 0 | For |
| T. Rowe Price | 70,983 | 0 | 0 | 0 | For |
| TIAA | 59,129 | 0 | 0 | 0 | For |
| BOSTON TRUST WALDEN FUNDS | 48,640 | 0 | 0 | 0 | For |
| Jackson National | 48,623 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 45,509 | 0 | 0 | 0 | For |
| John Hancock | 44,426 | 0 | 0 | 0 | For |
| Advisers Investment Trust | 42,400 | 0 | 0 | 0 | For |
Showing the 25 largest of 128 asset managers. All 128 are in the interactive database (link above).
Combines 4 wordings of this item as funds reported it.
97% Approved · of votes cast
Description as filed by funds: To approve the Medpace Holdings, Inc. 2016 Amended and Restated Incentive Award Plan.
MEDPACE HOLDINGS INC.’s own tally for this item (“4. Approval of the Company's 2016 Amended and Restated Incentive Award Plan The proposal to approve the Company's 2016 Amended and Restated Incentive Award Plan”): 25,567,981 for, 702,406 against — passed, per its Form 8-K filed May 16, 2025 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Proposal 4 —Approval of the Company's 2016 Amended and Restated Incentive Award Plan The proposal to approve the Company's 2016 Amended and Restated Incentive Award Plan was approved based upon the following votes:”
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Also reported under other wordings, matched to the same row of MEDPACE HOLDINGS INC.’s official tally and shown with their own fund figures; their managers are not in the figures or the table on this card: “Amend Omnibus Stock Plan” (7 managers, Fund and manager reports combined; may count the same shares twice; no share total shown); “Amend Stock Option Plan” (2 managers, 1,800 for, 13 unknown).
The 131 asset managers below reported 8,902,384 for, 23,757 against, 4,831 abstained, 57 not voted.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,789,333 | 0 | 0 | 0 | For |
| BlackRock | 1,573,065 | 0 | 0 | 0 | For |
| Fidelity | 688,837 | 0 | 0 | 0 | For |
| WASATCH FUNDS TRUST | 430,392 | 0 | 0 | 0 | For |
| Invesco | 329,184 | 0 | 0 | 0 | For |
| Dimensional | 201,673 | 0 | 0 | 0 | For |
| Charles Schwab | 198,966 | 0 | 0 | 0 | For |
| OLD WESTBURY FUNDS INC | 187,684 | 0 | 0 | 0 | For |
| Legg Mason | 176,056 | 0 | 0 | 0 | For |
| State Street | 162,002 | 5 | 0 | 0 | For |
| Manager Directed Portfolios | 131,563 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 130,635 | 0 | 0 | 0 | For |
| Thrivent | 120,238 | 0 | 0 | 0 | For |
| FINANCIAL INVESTORS TRUST | 105,192 | 0 | 0 | 0 | For |
| Putnam | 85,202 | 0 | 0 | 0 | For |
| CARILLON SERIES TRUST | 84,045 | 0 | 0 | 0 | For |
| JPMorgan | 80,308 | 0 | 0 | 0 | For |
| Goldman Sachs | 77,395 | 0 | 0 | 0 | For |
| Capitol Series Trust | 73,213 | 0 | 0 | 0 | For |
| T. Rowe Price | 70,983 | 0 | 0 | 0 | For |
| TIAA | 59,129 | 0 | 0 | 0 | For |
| BOSTON TRUST WALDEN FUNDS | 48,640 | 0 | 0 | 0 | For |
| Jackson National | 48,623 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 42,636 | 2,873 | 0 | 0 | Mixed |
| John Hancock | 44,426 | 0 | 0 | 0 | For |
Showing the 25 largest of 131 asset managers. All 131 are in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
95% Approved · of votes cast
Prior year: 97.4% for (May 17, 2024 meeting) ▼ 2.5 pts
Description as filed by funds: To approve, on an advisory basis, the compensation of our named executive officers as disclosed in the proxy statement for the 2025 Annual Meeting.
MEDPACE HOLDINGS INC.’s own tally for this item (“3. Advisory Vote on the Compensation of our Named Executive Officers The proposal to approve, on an advisory basis, the compensation of the Company's Named Executive Officers”): 24,918,234 for, 1,340,033 against — passed, per its Form 8-K filed May 16, 2025 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Proposal 3 — Advisory Vote on the Compensation of our Named Executive Officers The proposal to approve, on an advisory basis, the compensation of the Company's Named Executive Officers was approved based upon the following votes:”
Support: 95% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Also reported under other wordings, matched to the same row of MEDPACE HOLDINGS INC.’s official tally and shown with their own fund figures; their managers are not in the figures or the table on this card: “Advisory Vote to Ratify Named Executive Officers' Compensation” (29 managers, Fund and manager reports combined; may count the same shares twice; no share total shown); “To approve, on an advisory basis, the H of our named executive officers as disclosed in the proxy statement for the 2025 Annual Meeting.” (2 managers, 75,538 for).
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,789,140 | 193 | 0 | 0 | For |
| BlackRock | 1,573,065 | 0 | 0 | 0 | For |
| Fidelity | 688,837 | 0 | 0 | 0 | For |
| WASATCH FUNDS TRUST | 430,392 | 0 | 0 | 0 | For |
| Invesco | 329,184 | 0 | 0 | 0 | For |
| Dimensional | 201,673 | 0 | 0 | 0 | For |
| Charles Schwab | 198,966 | 0 | 0 | 0 | For |
| OLD WESTBURY FUNDS INC | 187,684 | 0 | 0 | 0 | For |
| Legg Mason | 176,056 | 0 | 0 | 0 | For |
| State Street | 162,002 | 5 | 0 | 0 | For |
| Manager Directed Portfolios | 131,563 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 130,635 | 0 | 0 | 0 | For |
| Thrivent | 120,238 | 0 | 0 | 0 | For |
| FINANCIAL INVESTORS TRUST | 105,192 | 0 | 0 | 0 | For |
| Putnam | 85,202 | 0 | 0 | 0 | For |
| CARILLON SERIES TRUST | 84,045 | 0 | 0 | 0 | For |
| JPMorgan | 80,308 | 0 | 0 | 0 | For |
| Goldman Sachs | 77,395 | 0 | 0 | 0 | For |
| T. Rowe Price | 70,983 | 0 | 0 | 0 | For |
| TIAA | 59,129 | 0 | 0 | 0 | For |
| BOSTON TRUST WALDEN FUNDS | 48,640 | 0 | 0 | 0 | For |
| Jackson National | 48,623 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 42,636 | 2,873 | 0 | 0 | Mixed |
| John Hancock | 44,426 | 0 | 0 | 0 | For |
| Advisers Investment Trust | 42,400 | 0 | 0 | 0 | For |
Fund voting reports, all 124 managers: 8,801,151 for, 47,833 against, 4,831 abstained, 57 not voted. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 783,098 | 150 | 0 | 0 | For |
| State Street | 691,186 | 9,335 | 0 | 0 | For |
| BESSEMER TRUST Co NATIONAL ASSOCIATION | 662,234 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 658,670 | 0 | 0 | 0 | For |
| Invesco | 631,327 | 1,346 | 0 | 0 | For |
| Mawer Investment Management Ltd. | 632,341 | 0 | 0 | 0 | For |
| WASATCH ADVISORS LP | 585,589 | 0 | 0 | 0 | For |
| BESSEMER TRUST Co OF FLORIDA | 445,540 | 0 | 0 | 0 | For |
| Bessemer Trust CO of Delaware, N.A. | 421,405 | 0 | 0 | 0 | For |
| Clearbridge Investments, LLC | 401,305 | 0 | 0 | 0 | For |
| RIVERBRIDGE PARTNERS LLC | 399,596 | 0 | 0 | 0 | For |
| BESSEMER TRUST CO | 395,195 | 0 | 0 | 0 | For |
| Bessemer Trust Co of Nevada, National Association | 382,149 | 0 | 0 | 0 | For |
| BESSEMER INVESTMENT MANAGEMENT LLC | 375,368 | 0 | 0 | 0 | For |
| Bessemer Trust Co of California, N.A. | 375,368 | 0 | 0 | 0 | For |
| Epoch Investment Partners, Inc. | 361,745 | 0 | 0 | 0 | For |
| Vulcan Value Partners, LLC | 302,063 | 295 | 0 | 0 | For |
| Northern Trust | 282,826 | 2,234 | 0 | 0 | For |
| Spyglass Capital Management LLC | 254,595 | 0 | 0 | 0 | For |
| GW&K Investment Management, LLC | 37,187 | 0 | 0 | 0 | For |
| Giverny Capital Inc. | 225,276 | 0 | 0 | 0 | For |
| Charles Schwab | 202,029 | 0 | 0 | 0 | For |
| CAISSE DE DEPOT ET PLACEMENT DU QUEBEC | 0 | 167,386 | 0 | 0 | Against |
| SEB Investment Management AB | 0 | 164,797 | 0 | 0 | Against |
| MELLON INVESTMENTS Corp | 162,941 | 0 | 0 | 0 | For |
Institutional-manager reports, all 432 managers: 14,030,345 for, 1,009,137 against, 10,000 abstained, 2,094 not voted, 201,929 mixed. Showing the 25 largest; every one is in the interactive database (link above).
Combines 4 wordings of this item as funds reported it.
98% Approved · of votes cast
Prior year: 97.2% for (May 17, 2024 meeting) ▲ 0.6 pts
Description as filed by funds: To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025.
MEDPACE HOLDINGS INC.’s own tally for this item (“2. Ratification of Appointment of Independent Registered Public Accounting Firm The appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December ”): 27,200,285 for, 600,429 against — passed, per its Form 8-K filed May 16, 2025 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Proposal 2 — Ratification of Appointment of Independent Registered Public Accounting Firm The appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025 was ratified based upon the following votes:”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 131 asset managers below reported 8,881,131 for, 65,322 against, 4,831 abstained, 57 not voted.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,789,140 | 193 | 0 | 0 | For |
| BlackRock | 1,573,065 | 0 | 0 | 0 | For |
| Fidelity | 688,837 | 0 | 0 | 0 | For |
| WASATCH FUNDS TRUST | 430,392 | 0 | 0 | 0 | For |
| Invesco | 329,184 | 0 | 0 | 0 | For |
| Dimensional | 201,673 | 0 | 0 | 0 | For |
| Charles Schwab | 198,966 | 0 | 0 | 0 | For |
| OLD WESTBURY FUNDS INC | 187,684 | 0 | 0 | 0 | For |
| Legg Mason | 176,056 | 0 | 0 | 0 | For |
| State Street | 162,002 | 5 | 0 | 0 | For |
| Manager Directed Portfolios | 131,563 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 130,635 | 0 | 0 | 0 | For |
| Thrivent | 120,238 | 0 | 0 | 0 | For |
| FINANCIAL INVESTORS TRUST | 105,192 | 0 | 0 | 0 | For |
| Putnam | 85,202 | 0 | 0 | 0 | For |
| CARILLON SERIES TRUST | 84,045 | 0 | 0 | 0 | For |
| JPMorgan | 80,308 | 0 | 0 | 0 | For |
| Goldman Sachs | 77,395 | 0 | 0 | 0 | For |
| Capitol Series Trust | 73,213 | 0 | 0 | 0 | For |
| T. Rowe Price | 70,983 | 0 | 0 | 0 | For |
| TIAA | 59,129 | 0 | 0 | 0 | For |
| BOSTON TRUST WALDEN FUNDS | 48,640 | 0 | 0 | 0 | For |
| Jackson National | 48,623 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 45,509 | 0 | 0 | 0 | For |
| John Hancock | 44,426 | 0 | 0 | 0 | For |
Showing the 25 largest of 131 asset managers. All 131 are in the interactive database (link above).
Combines 4 wordings of this item as funds reported it.
69% Approved · of votes cast
Description as filed by funds: Stockholder proposal regarding implementation of simple majority voting, if properly presented at the meeting.
MEDPACE HOLDINGS INC.’s own tally for this item (“5. Advisory Vote on Stockholder Proposal The non-binding advisory stockholder proposal regarding simple majority voting”): 18,210,462 for, 8,021,457 against — passed, per its Form 8-K filed May 16, 2025 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Proposal 5 — Advisory Vote on Stockholder Proposal The non-binding advisory stockholder proposal regarding simple majority voting was approved based upon the following votes:”
Support: 69% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 130 asset managers below reported 8,169,705 for, 769,508 against, 5,440 withheld, 4,831 abstained, 57 not voted.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,789,309 | 24 | 0 | 0 | For |
| BlackRock | 1,573,065 | 0 | 0 | 0 | For |
| Fidelity | 688,837 | 0 | 0 | 0 | For |
| WASATCH FUNDS TRUST | 0 | 430,392 | 0 | 0 | Against |
| Invesco | 329,184 | 0 | 0 | 0 | For |
| Dimensional | 201,673 | 0 | 0 | 0 | For |
| Charles Schwab | 198,966 | 0 | 0 | 0 | For |
| OLD WESTBURY FUNDS INC | 187,684 | 0 | 0 | 0 | For |
| Legg Mason | 176,056 | 0 | 0 | 0 | For |
| State Street | 161,971 | 36 | 0 | 0 | For |
| Manager Directed Portfolios | 0 | 131,563 | 0 | 0 | Against |
| Columbia Threadneedle | 130,635 | 0 | 0 | 0 | For |
| Thrivent | 120,238 | 0 | 0 | 0 | For |
| FINANCIAL INVESTORS TRUST | 0 | 105,192 | 0 | 0 | Against |
| Putnam | 85,202 | 0 | 0 | 0 | For |
| CARILLON SERIES TRUST | 84,045 | 0 | 0 | 0 | For |
| JPMorgan | 80,308 | 0 | 0 | 0 | For |
| Goldman Sachs | 77,395 | 0 | 0 | 0 | For |
| Capitol Series Trust | 73,213 | 0 | 0 | 0 | For |
| T. Rowe Price | 70,983 | 0 | 0 | 0 | For |
| TIAA | 59,129 | 0 | 0 | 0 | For |
| BOSTON TRUST WALDEN FUNDS | 48,640 | 0 | 0 | 0 | For |
| Jackson National | 48,623 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 45,509 | 0 | 0 | 0 | For |
| John Hancock | 44,426 | 0 | 0 | 0 | For |
Showing the 25 largest of 130 asset managers. All 130 are in the interactive database (link above).
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 29,836,211 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 9.35% |
| 2 | BlackRock | 5.27% |
| 3 | Fidelity | 2.31% |
| 4 | WASATCH FUNDS TRUST | 1.44% |
| 5 | Invesco | 1.10% |
| 6 | Dimensional | 0.68% |
| 7 | Charles Schwab | 0.67% |
| 8 | OLD WESTBURY FUNDS INC | 0.63% |
| 9 | Legg Mason | 0.59% |
| 10 | State Street | 0.54% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | BlackRock | 2.63% |
| 2 | State Street | 2.35% |
| 3 | BESSEMER TRUST Co NATIONAL ASSOCIATION | 2.22% |
| 4 | GEODE CAPITAL MANAGEMENT, LLC | 2.21% |
| 5 | Invesco | 2.12% |
| 6 | Mawer Investment Management Ltd. | 2.12% |
| 7 | WASATCH ADVISORS LP | 1.96% |
| 8 | BESSEMER TRUST Co OF FLORIDA | 1.49% |
| 9 | Bessemer Trust CO of Delaware, N.A. | 1.41% |
| 10 | Clearbridge Investments, LLC | 1.35% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.
| Holder | Shares | % outstanding | Source, as of |
|---|---|---|---|
| August J. Troendle | 5,682,934 | 19.05% | Schedule 13D, filed December 1, 2025 |
| Medpace Investors, LLC | 4,733,019 | 15.86% | Proxy statement (DEF 14A), table as of March 20, 2025 |
| BlackRock | 2,688,123 | 9.01% | Form 13F, quarter ended March 31, 2025 |
| Vanguard Group | 2,533,606 | 8.49% | Form 13F, quarter ended March 31, 2025 |
| Invesco | 1,186,768 | 3.98% | Form 13F, quarter ended March 31, 2025 |
| State Street | 782,986 | 2.62% | Form 13F, quarter ended March 31, 2025 |
| Geode Capital | 668,203 | 2.24% | Form 13F, quarter ended March 31, 2025 |
| Renaissance Technologies | 577,688 | 1.94% | Form 13F, quarter ended March 31, 2025 |
| AQR Capital | 539,547 | 1.81% | Form 13F, quarter ended March 31, 2025 |
| Northern Trust | 337,489 | 1.13% | Form 13F, quarter ended March 31, 2025 |
Percentages above are of 29,836,211 shares outstanding, as reported by MEDPACE HOLDINGS INC. on its Form 10-Q dated March 31, 2025 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
At MEDPACE HOLDINGS INC.'s shareholder meeting held May 16, 2025, in the 2024-2025 proxy season, 556 asset managers reported votes on at least one of its 6 ballot items in their SEC Form N-PX filings, covering 3,503 separate fund positions. On the most widely held item on that ballot — To approve, on an advisory basis, the compensation of our named executive officers as disclosed… — MEDPACE HOLDINGS INC.'s filing reports the proposal as approved, with 95% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: MEDPACE HOLDINGS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on May 16, 2025.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from MEDPACE HOLDINGS INC.’s 10-Q dated March 31, 2025. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.
MEDPACE HOLDINGS INC. proxy season coverage: 2023-2024 · 2024-2025 (this page) · 2025-2026.
Proxy Votes Now, “MEDPACE HOLDINGS (MEDP) 2025 Annual Meeting: Shareholder Vote Results”, https://proxyvotesnow.com/company/medpace-holdings-inc/2025 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.